Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
133.72
+0.91 (0.69%)
Nov 20, 2026, 4:00 PM EST - Market closed
Merck & Co. Employees
Merck & Co. had 75,000 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Merck & Co. the 457th largest employer in the world and 122nd in the United States.
Employees
75,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$898,373
Profits / Employee
$32,707
Market Cap
329.65B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75,000 | 0 | - |
| Dec 31, 2024 | 75,000 | 3,000 | 4.17% |
| Dec 31, 2023 | 72,000 | 3,000 | 4.35% |
| Dec 31, 2022 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2021 | 68,000 | -6,000 | -8.11% |
| Dec 31, 2020 | 74,000 | 3,000 | 4.23% |
| Dec 31, 2019 | 71,000 | 2,000 | 2.90% |
| Dec 31, 2018 | 69,000 | 0 | - |
| Dec 31, 2017 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2016 | 68,000 | 0 | - |
| Dec 31, 2015 | 68,000 | -2,000 | -2.86% |
| Dec 31, 2014 | 70,000 | -6,000 | -7.89% |
| Dec 31, 2013 | 76,000 | -7,000 | -8.43% |
| Dec 31, 2012 | 83,000 | -3,000 | -3.49% |
| Dec 31, 2011 | 86,000 | -8,000 | -8.51% |
| Dec 31, 2010 | 94,000 | -6,000 | -6.00% |
| Dec 31, 2009 | 100,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| GSK plc | 66,841 |
| Novo Nordisk | 66,700 |
| AbbVie | 57,000 |
MRK News
- 1 day ago - Merck's drug prolongs survival in advanced stomach, esophageal cancers in trial - Reuters
- 1 day ago - Merck says 3 TroFuse-015 trial of sacituzumab tirumotecan met primary endpoint - TheFly
- 2 days ago - Halozyme provides update on German preliminary injunction hearing - TheFly
- 2 days ago - Merck and Isomorphic Labs to collaborate in drug discovery - TheFly
- 2 days ago - Merck and Isomorphic Labs Enter Strategic Research Collaboration - Business Wire
- 2 days ago - Merck & Co. Transcript: Jefferies Global Healthcare Conference - Transcripts
- 3 days ago - Merck says Thomas Glocer to retire from board of directors - TheFly
- 3 days ago - Thomas H. Glocer to Retire From Merck Board of Directors in May 2027; Douglas M. Baker, Jr. Appointed Independent Lead Director - Business Wire